RECHEM
Welcome to our website!|Hot Line: 86-21-31433387|E-mail: sales@rechemscience.com
Products Category
Contact Us
| Tel: | +86-21-31433387 |
| +86-15618786686 | |
| Email: | sales@rechemscience.com |
| info@rechemscience.com | |
| QQ: | 1369748377 |
| Skype: | sales@rechemscience.com |
Home > Products
| Cat.No. | Product name | Product Description |
| R10001 | R788; Fostamatinib | Fostamatinib (R788), a prodrug of the active metabolite R406, is a Syk inhibitor |
| R10002 | R406 Free base | R406 (free base) is a potent Syk inhibitor with IC50 of 41 nM in a cell-free ass |
| R10003 | Infigratinib (Synonyms: BGJ-398; NVP-BGJ398) | BGJ398 (NVP-BGJ398) is a potent and selective FGFR inhibitor for FGFR1/2/3 with |
| R10004 | VX-809; Lumacaftor | VX-809 (Lumacaftor) acts to correct CFTR mutations common in cystic fibrosis by |
| R10005 | AT406 (SM-406, ARRY-334543) | AT-406 is an orally bioavailable inhibitor of IAP family of proteins with potent |
| R10006 | Allitinib tosylate (Synonyms: AST-1306 (TsOH))/897383-62-9 Free base | AST-1306 is a novel irreversible inhibitor of EGFR and ErbB2 with IC50 of 0.5 nM |
| R10007 | AZD6244 | Selumetinib (AZD6244) is a potent, highly selective MEK1 inhibitor with IC50 of |
| R10008 | Rucaparib phosphate; AG014699; PF01367388 | Rucaparib (AG-014699, PF-01367338) is an inhibitor of PARP with Ki of 1.4 nM for |
| R10009 | AZD8055 | AZD8055 is a novel ATP-competitive mTOR inhibitor with IC50 of 0.8 nM in MDA-MB- |
| R10010 | Rucaparib; AG-014699; PF-01367388 | Rucaparib (AG-014699, PF-01367338) is an inhibitor of PARP with Ki of 1.4 nM for |
| R10011 | BIO-acetoxime; GSK3 Inhibitor IX | BIO-acetoxime is a potent dual GSK3α/β inhibitor with IC50 of 10 nM, >240-fol |
| R10012 | NVP-HSP990 (HSP990) | NVP-HSP990 (HSP990) is a novel, potent and selective HSP90 inhibitor for HSP90α/ |
| R10013 | PF 04691502 | PF-04691502 is an ATP-competitive PI3K(α/β/δ/γ)/mTOR dual inhibitor with Ki of 1 |
| R10014 | AKT inhibitor VIII (AKTI-1/2) | CAS NO.：612847-09-3Product Name：1-(1-(4-(6-Phenyl-1H-imidazo[4,5-g]quinoxalin-7- |
| R10015 | MN-64 | MN-64 is a inhibitor of tankyrases, showed 6 nM potency against tankyrase 1, iso |
| R10016 | TH287 | TH287 is a potent and selective MTH1 (NUDT1) inhibitor with IC50 of 0.8 nM. |
| R10019 | Setanaxib (Synonyms: GKT137831; GKT831) | Setanaxib (GKT137831) is a selective NADPH oxidase (NOX1/4) inhibitor with Kis o |
| R10020 | JNJ-31020028 | JNJ-31020028 is a selective brain penetrant antagonist of neuropeptide Y2 recept |
| R10022 | GSK429286A | GSK429286A is a selective inhibitor of ROCK1 and ROCK2 with IC50 of 14 nM and 63 |
| R10024 | Cardiogenol C hydrochloride | Cardiogenol C hydrochloride is a cell-permeable pyrimidine compound which potent |
| R10025 | MLN2238 | MLN2238 inhibits the chymotrypsin-like proteolytic (β5) site of the 20S proteaso |
| R10026 | Ruxolitinib (INCB018424) | CAS NO.：941678-49-5Product Name：β-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl |
| R10027 | KU-0063794 | KU-0063794 is a potent and highly specific dual-mTOR inhibitor of mTORC1 and mTO |
| R10028 | MLN9708 | MLN9708 immediately hydrolyzed to MLN2238, the biologically active form, on expo |
| R10029 | ML141 (CID-2950007) | ML141 is a potent, selective and reversible non-competitive inhibitor of Rho fam |
